Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 352

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 352
---
16.1 to the registrant’s Current Report on Form 8-K filed with the SEC on May 6, 2025).          
 List of Subsidiaries of Liminatus Pharma, Inc. (incorporated by reference to Exhibit 21.1 to the registrant’s Current Report on Form 8-K filed with the SEC on May 6, 2025). |
|:-------|:--|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 23.1*  | ​ | Consent of WithumSmith+Brown, PC — independent registered public accounting firm.                                                                                            |
| 23.2*  | ​ | Consent of WithumSmith+Brown, PC — independent registered public accounting firm.                                                                                            |
| 23.3*  | ​ | Consent of Marcum LLP.                                                                                                                                                       |
| 23.4*  | ​ | Consent of Loeb & Loeb LLP (included as part of Exhibit 5.1 hereto).                                                                                                         |
| 24.1** | ​ | Power of Attorney (contained on the signature page to this registration statement).                                                                                          |
| 107*   | ​ | Calculation of Registration Fee Table.                                                                                                                                       |

*Filed herewith. **Previously filed. Item 17. Undertakings. The undersigned registrant hereby undertakes: (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement. (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any